Fusion Antibodies
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Fusion Antibodies's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 76% to $1,136,000. Profit margin reached -196%. Total operating expenses were $2,027,000.
Profit Margin
| 2015 | 909.29K | -85.11K | -9.36% |
|---|---|---|---|
| 2016 | 1.48M | 1.15M | 77.91% |
| 2018 | 2.69M | -699.94K | -26.01% |
| 2019 | 2.18M | -1.26M | -57.95% |
| 2021 | 4.16M | -2.89M | -69.6% |
| 2022 | 4.79M | -1.2M | -25.01% |
| 2024 | 1.13M | -2.22M | -195.95% |
FAB.L Income Statement (2014 – 2023)
| 2023 | 2021 | 2020 | 2018 | 2017 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 1.13M | 4.79M | 4.16M | 2.18M | 2.69M | 1.48M | 909.29K |
Cost of revenue | 1.40M | 3.08M | 2.85M | 1.37M | 1.20M | 618.05K | 460.44K |
Gross profit | -265K | 1.71M | 1.31M | 804.00K | 1.48M | 863.21K | 448.85K |
Operating exp. | |||||||
Research and development | 254K | 699K | 613K | 240K | 69K | 0 | 0 |
Selling and marketing | -474K | -679K | -668K | 0 | 2.99K | 0 | 0 |
Total operating expenses | 2.02M | 3.04M | 2.68M | 2.31M | 2.19M | 835.52K | 547.64K |
Operating income | -2.28M | -1.33M | -1.37M | -1.50M | 62.39K | 27.68K | -98.78K |
Other income (expenses), net | -1K | -1K | -15K | 9K | -773.75K | -496 | -664 |
Income before tax | -2.28M | -1.33M | -1.26M | -1.49M | -711.36K | 27.18K | -99.45K |
Income tax expense | -63K | -133K | 1.63M | -235.48K | 11.42K | -1.12M | -14.33K |
Net income | -2.22M | -1.2M | -2.89M | -1.26M | -699.94K | 1.15M | -85.11K |
Earnings per share | |||||||
Basic EPS | -0.04 | -0.04 | -0.11 | -0.05 | -0.04 | 0.05 | -0.00 |
Diluted EPS | -0.04 | -0.04 | -0.11 | -0.05 | -0.04 | 0.05 | -0.00 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |